2023 / 04

Следующая статья
DOI: 10.47183/mes.2023.064

ОБЗОР

Аллергия на латекс

С. В. Гулько1, Г. Ю. Бабаджанова1,2
Информация об авторах

1 Московский государственный университет имени М. В. Ломоносова Министерства образования России, Москва, Россия

2 Научно-исследовательский институт пульмонологии Федерального медико-биологического агентства, Москва, Россия

Для корреспонденции: Гульнара Юсуповна Бабаджанова
Ореховый бульвар, д. 28, г. Москва, 115682, Россия; ur.relbmar@avonajdabab

Информация о статье

Вклад авторов: С. В. Гулько — поиск литературы и оформление работы; Г. Ю. Бабаджанова — руководство, редакция, внесение правок.

Статья получена: 08.11.2023 Статья принята к печати: 15.12.2023 Опубликовано online: 31.12.2023
|
  1. Jacob JL, d'Auzac J, Prevot JC. The composition of natural latex ̂ from Hevea brasiliensis. Clin Rev Allergy. 1993; 11: 325.
  2. Alenius H, Kurup V, Kelly K, et al. Latex allergy: frequent occurrence of IgE antibodies to a cluster of 11 latex proteins in patients with spina bifida and histories of anaphylaxis. J Lab Clin Med. 1994; 123: 712.
  3. Breiteneder H, Scheiner O. Molecular and immunological characteristics of latex allergens. Int Arch Allergy Immunol. 1998; 116: 83.
  4. Smith AM, Amin HS, Biagini RE, et al. Percutaneous reactivity to natural rubber latex proteins persists in health-care workers following avoidance of natural rubber latex. Clin Exp Allergy. 2007; 37: 1349.
  5. Palosuo T, Alenius H, Turjanmaa K. Quantitation of latex allergens. Methods 2002; 27: 52.
  6. Nowakowska-Świrta E, Wiszniewska M, Walusiak-Skorupa J. Allergen-specific IgE to recombinant latex allergens in occupational allergy diagnostics. J Occup Health. 2019; 61: 378.
  7. Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol. 2001; 108: 881.
  8. Blanco C, Diaz-Perales A, Collada C, et al. Class I chitinases as potential panallergensinvolved in the latex-fruit syndrome. J Allergy Clin Immunol. 1999; 103: 507.
  9. Wright HT, Brooks DM, Wright CS. Evolution of the multi-domain protein wheat germ agglutinin. J Mol Evol. 1985; 21: 28091.
  10. Chen Z, Posch A, Cremer R, et al. Identification of hevein (Hev b 6.02) in Hevea latex as a major cross-reacting allergen with avocado fruit in patients with latex allergy. J Allergy Clin Immunol. 1998; 102: 476.
  11. Archer BL, Barnard D, Cockbain EG, et al. Structure, composition and biochemistry of Hevea latex. In: Bateman L, editor. The chemistry and physics of rubber-like substances. New York: John Wiley & Sons, 1963; p. 41.
  12. Vandenplas O, Larbanois A, Vanassche F, et al. Latex-induced occupational asthma: time trend in incidence and relationship with hospital glove policies. Allergy. 2009; 64: 415.
  13. Kelly KJ, Sussman G. Latex Allergy: Where Are We Now and How Did We Get There? J Allergy Clin Immunol Pract. 2017; 5: 1212.
  14. Hamann CP, Kick SA. Allergies associated with medical gloves. Manufacturing issues. Dermatol Clin. 1994; 12: 547.
  15. Truscott W, Roley L. Glove-associated reactions: addressing an increasing concern. Dermatol Nurs. 1995; 7: 283.
  16. Mari A, Scala E, D'Ambrosio C, et al. Latex allergy within a cohort of not-at-risk subjects with respiratory symptoms: prevalence of latex sensitization and assessment of diagnostic tools. Int Arch Allergy Immunol. 2007; 143: 135.
  17. Turjanmaa K. Incidence of immediate allergy to latex gloves in hospital personnel. Contact Dermatitis. 1987; 17: 270.
  18. Kostyal D, Horton K, Beezhold D, et al. Latex as a significant source of Hevea brasiliensis allergen exposure. Ann Allergy Asthma Immunol. 2009; 103: 354.
  19. Liu QL, He XZ, Liang K, et al. Prevalence and risk factors for latex glove allergy among female clinical nurses: a multicenter questionnaire study in China. Int J Occup Environ Health. 2013; 19: 29.
  20. Parisi CA, Petriz NA, Busaniche JN, et al. Prevalence of latex allergy in a population of patients diagnosed with myelomeningocele. Arch Argent Pediatr. 2016; 114: 30.
  21. Brown RH, Hamilton RG, Mintz M, et al. Genetic predisposition to latex allergy: role of interleukin 13 and interleukin 18. Anesthesiology. 2005; 102: 496.
  22. Monitto CL, Hamilton RG, Levey E, et al. Genetic predisposition to natural rubber latex allergy differs between health care workers and high-risk patients. Anesth Analg. 2010; 110: 1310.
  23. Charous BL, Tarlo SM, Charous MA, Kelly K. Natural rubber latex allergy in the occupational setting. Methods. 2002; 27: 15.
  24. Heese A, van Hintzenstern J, Peters KP, et al. Allergic and irritant reactions to rubber gloves in medical health services. Spectrum, diagnostic approach, and therapy. J Am Acad Dermatol. 1991; 25: 831.
  25. Sussman G, Gold M. Guidelines for the management of latex allergies and safe latex use in health care facilities. Am College of Allergy Asthma and Immunology, 1996; p. 56.
  26. Williams JD, Lee AY, Matheson MC, et al. Occupational contact urticaria: Australian data. Br J Dermatol. 2008; 159: 125.
  27. Kimata H. Latex allergy in infants younger than 1 year. Clin Exp Allergy. 2004; 34: 1910.
  28. Cogen FC, Beezhold DH. Hair glue anaphylaxis: a hidden latex allergy. Ann Allergy Asthma Immunol. 2002; 88: 61.
  29. Hamilton RG. Diagnosis of natural rubber latex allergy. Methods. 2002; 27: 22.
  30. Hamilton RG, Scheer DI, Gruchalla R, et al. Casein-related anaphylaxis after use of an Everlast kickboxing glove. J Allergy Clin Immunol. 2015; 135: 269.
  31. Hamilton RG, Adkinson NF Jr. Natural rubber latex skin testing reagents: safety and diagnostic accuracy of nonammoniated latex, ammoniated latex, and latex rubber glove extracts. J Allergy Clin Immunol. 1996; 98: 872.
  32. Hamilton RG, Biagini RE, Krieg EF. Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-specific IgE antibody. The Multi-Center Latex Skin Testing Study Task Force. J Allergy Clin Immunol. 1999; 103: 925.
  33. Bernardini R, Pucci N, Azzari C, et al. Sensitivity and specificity of different skin prick tests with latex extracts in pediatric patients with suspected natural rubber latex allergy — a cohort study. Pediatr Allergy Immunol. 2008; 19: 315.
  34. Hamilton RG, Adkinson NF Jr. Validation of the latex glove provocation procedure in latex-allergic subjects. Ann Allergy Asthma Immunol. 1997; 79: 266.
  35. Kelly KJ, Kurup V, Zacharisen M, et al. Skin and serologic testing in the diagnosis of latex allergy. J Allergy Clin Immunol. 1993; 91: 1140.
  36. Biagini RE, Krieg EF, Pinkerton LE, Hamilton RG. Receiver operating characteristics analyses of Food and Drug Administration-cleared serological assays for natural rubber latexspecific immunoglobulin E antibody. Clin Diagn Lab Immunol. 2001; 8: 1145.
  37. Hamilton RG, Biagini R, Mackenzie B, et al. FDA cleared immunoassays for latex- specific IGE are missing allergenic epitopes from multiple Hev b allergens. J Allergy Clin Immunol. 2002; 109: S259.
  38. Seyfarth F, Schliemann S, Wiegand C, et al. Diagnostic value of the ISAC (®) allergy chip in detecting latex sensitizations. Int Arch Occup Environ Health. 2014; 87: 775.
  39. Ott H, Schröder C, Raulf-Heimsoth M, et al. Microarrays of recombinant Hevea brasiliensis proteins: a novel tool for the component-resolved diagnosis of natural rubber latex allergy. J Investig Allergol Clin Immunol. 2010; 20: 129.
  40. Schuler S, Ferrari G, Schmid-Grendelmeier P, Harr T. Microarraybased component- resolved diagnosis of latex allergy: isolated IgE-mediated sensitization to latexprofilin Hev b8 may act as confounder. Clin Transl Allergy. 2013; 3: 11.
  41. Kurtz KM, Hamilton RG, Adkinson NF Jr. Role and application of provocation in the diagnosis of occupational latex allergy. Ann Allergy Asthma Immunol. 1999; 83: 634.
  42. Laoprasert N, Swanson MC, Jones RT, et al. Inhalation challenge testing of latex- sensitive health care workers and the effectiveness of laminar flow HEPA-filtered helmets in reducing rhinoconjunctival and asthmatic reactions. J Allergy Clin Immunol. 1998; 102: 998.
  43. Kurtz KM, Hamilton RG, Schaefer JA, et al. Repeated latex aeroallergen challenges employing a hooded exposure chamber: safety and reproducibility. Allergy. 2001; 56: 857.
  44. Bernardini R, Pucci N, Rossi ME, et al. Allergen specific nasal challenge to latex in children with latex allergy: clinical and immunological evaluation. Int J Immunopathol Pharmacol. 2008; 21: 333.
  45. Unsel M, Mete N, Ardeniz O, et al. The importance of nasal provocation test in the diagnosis of natural rubber latex allergy. Allergy. 2009; 64: 862.
  46. Bernstein DI. Management of natural rubber latex allergy. J Allergy Clin Immunol. 2002; 110: S111.
  47. Sutherland MF, Suphioglu C, Rolland JM, O'Hehir RE. Latex allergy: towards immunotherapy for health care workers. Clin Exp Allergy. 2002; 32: 667.
  48. Kelly KJ, Wang ML, Klancnik M, Petsonk EL. Prevention of IgE Sensitization to Latex in Health Care Workers After Reduction of Antigen Exposures. J Occup Environ Med. 2011; 53: 934.
  49. Blumchen K, Bayer P, Buck D, et al. Effects of latex avoidance on latex sensitization, atopy and allergic diseases in patients with spina bifida. Allergy. 2010; 65: 1585.
  50. Rolland JM, O'Hehir RE. Latex allergy: a model for therapy. Clin Exp Allergy. 2008; 38: 898.
  51. Nucera E, Schiavino D, Sabato V, et al. Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase. Curr Med Res Opin. 2008; 24: 1147.
  52. Chang TW, Wu PC, Hsu CL, Hung AF. Anti-IgE antibodies for the treatment of IgE- mediated allergic diseases. Adv Immunol. 2007; 93: 63.
  53. Leynadier F, Doudou O, Gaouar H, et al. Effect of omalizumab in health care workers with occupational latex allergy. J Allergy Clin Immunol. 2004; 113: 360.
  54. Cusick C. A latex-safe environment is in everyone's best interest. Mater Manag Health Care. 2007; 16: 24.
  55. SGNA Practice Committee. Guideline for preventing sensitivity and allergic reactions to natural rubber latex in the workplace. Gastroenterol Nurs. 2008; 31: 239.
  56. Kelly KJ, Sussman G. Latex Allergy: Where Are We Now and How Did We Get There? J Allergy Clin Immunol Pract 2017; 5: 1212.
  57. Bernstein DI, Karnani R, Biagini RE, et al. Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann Allergy Asthma Immunol. 2003; 90: 209.
  58. Cremer R, Kleine-Diepenbruck U, Hering F, Holschneider AM. Reduction of latex sensitisation in spina bifida patients by a primary prophylaxis programme (five years experience). Eur J Pediatr Surg. 2002; 12 (1): S19.
  59. Yunginger JW, Jones RT, Fransway AF, et al. Extractable latex allergens and proteins in disposable medical gloves and other rubber products. J Allergy Clin Immunol. 1994; 93: 836.
  60. Kujala V, Alenius H, Palosuo T, et al. Extractable latex allergens in airborne glove powder and in cut glove pieces. Clin Exp Allergy. 2002; 32: 1077.
  61. Truscott W. Glove powder reduction and alternative approaches. Methods. 2002; 27: 69.
  62. Koh D, Ng V, Leow YH, Goh CL. A study of natural rubber latex allergens in gloves used by healthcare workers in Singapore. Br J Dermatol. 2005; 153: 954.
  63. Palosuo T, Antoniadou I, Gottrup F, Phillips P. Latex medical gloves: time for a reappraisal. Int Arch Allergy Immunol. 2011; 156: 234.
  64. Brown RH, Hamilton RG, McAllister MA, Johns Hopkins. Latex Task Force. How health care organizations can establish and conduct a program for a latex-safe environment. Jt Comm J Qual Saf. 2003; 29: 113.
  65. Stinkens R, Verbeke N, Van de Velde M, et al. Safety of a powderfree latex allergy protocol in the operating theatre: A prospective, observational cohort study. Eur J Anaesthesiol. 2019; 36: 312.
  66. Palosuo T, Reinikka-Railo H, Kautiainen H, et al. Latex allergy: the sum quantity of four major allergens shows the allergenic potential of medical gloves. Allergy. 2007; 62: 781.
  67. Primeau MN, Adkinson NF Jr, Hamilton RG. Natural rubber pharmaceutical vial closures release latex allergens that produce skin reactions. J Allergy Clin Immunol. 2001; 107: 958.
  68. Hamilton RG, Brown RH, Veltri MA, et al. Administering pharmaceuticals to latex- allergic patients from vials containing natural rubber latex closures. Am J Health Syst Pharm. 2005; 62: 1822.
  69. Nienhaus A, Kromark K, Raulf-Heimsoth M, et al. Outcome of occupational latex allergy — work ability and quality of life. PLoS One. 2008; 3: e3459.
  70. Smith AM, Amin HS, Biagini RE, et al. Percutaneous reactivity to natural rubber latex proteins persists in health-care workers following avoidance of natural rubber latex. Clin Exp Allergy. 2007; 37: 1349.
  71. Palosuo T, Alenius H, Turjanmaa K. Quantitation of latex allergens. Methods. 2002; 27: 52.
  72. Vandenplas O, Raulf M. Occupational Latex Allergy: the Current State of Affairs. Curr Allergy Asthma Rep. 2017; 17: 14.
  73. Yeang HY, Arif SA, Yusof F, Sunderasan E. Allergenic proteins of natural rubber latex. Methods. 2002; 27: 32.
  74. Sussman GL, Beezhold DH, Kurup VP. Allergens and natural rubber proteins. J Allergy Clin Immunol. 2002; 110: S33.
  75. ASTM D7427-08. Standard test method for immunological measurement of four princi pal allergenic proteins (Hev b 1, 3, 5, 6.02) in natural rubber and its products derived from latex. American Society for Testing Materials, International, West Conshohocken, P A, 19428.
  76. Lee MF, Wang NM, Han JL, et al. Estimating allergenicity of latex gloves using Hev b 1 and hevamine. J Investig Allergol Clin Immunol. 2010; 20: 499.
  77. Baur X. I are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol. 2003; 90: 11.
  78. Beezhold DH, Kostyal DA, Tomazic-Jezic VJ. Measurement of latex proteins and assessment of latex protein exposure. Methods. 2002; 27: 46.
  79. ASTM D6499. Standard test method for the immunological measurement of antigenic protein in natural rubber and its products. American Society for Testing Materials, International, West Conshohocken, PA, 19428.
  80. ASTM D5712-05E1. Standard test method for analysis of aqueous extractable protein i n natural rubber and its products using the modified Lowry method. American Society for Testing Materials, International, West Conshohocken, PA, 19428.
  81. Renaud MY. Composition of synthetic latexes used for manufacturing gloves by dipping processes. Clin Rev Allergy. 1993; 11: 363.
  82. Siler DJ, Cornish K, Hamilton RG. Absence of cross-reactivity of IgE antibodies from subjects allergic to Hevea brasiliensis latex with a new source of natural rubber latex from guayule (Parthenium argentatum). J Allergy Clin Immunol. 1996; 98: 895.
  83. Carey AB, Cornish K, Schrank P, et al. Cross-reactivity of alternate plant sources of latex in subjects with systemic IgE-mediated sensitivity to Hevea brasiliensis latex. Ann Allergy Asthma Immunol. 1995; 74: 317.
  84. Sussman G, Gold M. Guidelines for the management of latex allergies and safe latex use in health care facilities. Am College of Allergy Asthma and Immunology. Available from: www.acaai.org/ public/physicians/latex.htm.
  85. Kostyal D, Horton K, Beezhold D, et al. Latex as a significant source of Hevea brasiliensis allergen exposure. Ann Allergy Asthma Immunol. 2009; 103: 354.
  86. Hamilton RG, Brown RH. Impact of personal avoidance practices on health care workers sensitized to natural rubber latex. J Allergy Clin Immunol. 2000; 105: 839.
  87. Bernstein DI, Biagini RE, Karnani R, et al. In vivo sensitization to purified Hevea brasiliensis proteins in health care workers sensitized to natural rubber latex. J Allergy Clin Immunol. 2003; 111: 610.
  88. Madan I, Cullinan P, Ahmed SM. Occupational management of type I latex allergy. Occup Med (Lond). 2013; 63: 395.
  89. Raulf M, Quirce S, Vandenplas O. Addressing Molecular Diagnosis of Occupational Allergies. Curr Allergy Asthma Rep. 2018; 18: 6.
  90. Beierwaltes P, Schoessler S. Latex Safe at School: A StudentCentered Approach. NASN Sch Nurse. 2017; 32: 343.
  91. Gentili A, Lima M, Ricci G, et al. Secondary prevention of latex allergy in children: analysis of results. Pediatr Med Chir. 2006; 28: 83.
  92. American Latex Allergy Association. Available from: www. latexallergyresources.org.
  93. Leynadier F, Herman D, Vervloet D, Andre C. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol. 2000; 106: 585.
  94. Turjanmaa K, Palosuo T, Alenius H, et al. Latex allergy diagnosis: in vivo and in vitro standardization of a natural rubber latex extract. Allergy. 1997; 52: 41.
  95. Sastre J, Fernandez-Nieto M, Rico P, et al. Specific immunotherapy ́ with a standardized latex extract in allergic workers: a double-blind, placebo-controlled study. J Allergy Clin Immunol. 2003; 111: 985.
  96. Patriarca G, Nucera E, Pollastrini E, et al. Sublingual desensitization: a new approach to latex allergy problem. Anesth Analg. 2002; 95: 956.
  97. Nettis E, Colanardi MC, Soccio AL, et al. Double-blind, placebocontrolled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study. Br J Dermatol. 2007; 156: 674.
  98. Bernardini R, Campodonico P, Burastero S, et al. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study. Curr Med Res Opin. 2006; 22: 1515.
  99. Nucera E, Schiavino D, Pollastrini E, et al. Sublingual desensitization in children with congenital malformations and latex allergy. Pediatr Allergy Immunol. 2006; 17: 606.
  100. Lasa Luaces EM, Tabar Purroy AI, García Figueroa BE, et al. Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children. Ann Allergy Asthma Immunol. 2012; 108: 367.
  101. Cistero BA, Sastre J, Enrique E, et al. Tolerance and effects on ́ skin reactivity to latex of sublingual rush immunotherapy with a latex extract. J Investig Allergol Clin Immunol. 2004; 14: 17.
  102. Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy. 2006; 61: 1236.
  103. Buyukozturk S, Gelincik A, Ozseker F, et al. Latex sublingual ̧ immunotherapy: can its safety be predicted? Ann Allergy Asthma Immunol. 2010; 104: 339.
  104. Nettis E, Delle DP, Di LE, et al. Latex immunotherapy: state of the art. Ann Allergy Asthma Immunol. 2012; 109: 160.
  105. Rolland JM, Drew AC, O'Hehir RE. Advances in development of hypoallergenic latex immunotherapy. Curr Opin Allergy Clin Immunol. 2005; 5: 544.